Cargando…

IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion

BACKGROUND: Studies from our laboratory and others have shown that cysteine-rich 61 (Cyr61) may be involved in tumor proliferation and invasion. In earlier studies, we demonstrated increased insulin-like growth factor-I (IGF-1) is associated with breast tumor formation and poor clinical outcomes. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarkissyan, Suren, Sarkissyan, Marianna, Wu, Yanyuan, Cardenas, Jessica, Koeffler, H. Phillip, Vadgama, Jaydutt V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111618/
https://www.ncbi.nlm.nih.gov/pubmed/25062088
http://dx.doi.org/10.1371/journal.pone.0103534
_version_ 1782328110166835200
author Sarkissyan, Suren
Sarkissyan, Marianna
Wu, Yanyuan
Cardenas, Jessica
Koeffler, H. Phillip
Vadgama, Jaydutt V.
author_facet Sarkissyan, Suren
Sarkissyan, Marianna
Wu, Yanyuan
Cardenas, Jessica
Koeffler, H. Phillip
Vadgama, Jaydutt V.
author_sort Sarkissyan, Suren
collection PubMed
description BACKGROUND: Studies from our laboratory and others have shown that cysteine-rich 61 (Cyr61) may be involved in tumor proliferation and invasion. In earlier studies, we demonstrated increased insulin-like growth factor-I (IGF-1) is associated with breast tumor formation and poor clinical outcomes. In our current study we have investigated IGF-1 regulation of Cyr61 and whether targeting IGF-1 could inhibit Cyr61 induced tumor growth and proliferation. METHODS: Several ATCC derived normal and breast cancer cell lines were used in this study: MDA-MB231, BT474, MCF-7, and SKBR3. We also tested cells stably transfected in our laboratory with active Akt1 (pAkt; SKBR3/AA and MCF-7/AA) and dominant negative Akt1 (SKBR3/DN and MCF-7/DN). In addition, we used MCF-7 cells transfected with full length Cyr61 (CYA). Monolayer cultures treated with IGF-1 were analyzed for Cyr61 expression by RT-PCR and immunohistochemical staining. Migration assays and MTT based proliferation assays were used to determine invasive characteristics in response to IGF-1/Cyr61 activation. RESULTS: Cells with activated Akt have increased levels of Cyr61. Conversely, cells with inactive Akt have decreased levels of Cyr61. IGF-1 treatment increased Cyr61 expression significantly and cells with high level of Cyr61 demonstrate increased invasiveness and proliferation. Cyr61 overexpression and activation led to decrease in E-cadherin and decrease in FOXO1. Inhibition of the PI3K and MAPK pathways resulted in significant decrease in invasiveness and proliferation, most notably in the PI3K pathway inhibited cells. CONCLUSION: The findings of this study show that IGF-1 upregulates Cyr61 primarily through activation of the Akt-PI3K pathway. IGF-1 induced MAPK plays a partial role. Increase in Cyr61 leads to increase in breast cancer cell growth and invasion. Hence, targeting Cyr61 and associated pathways may offer an opportunity to inhibit IGF-1 mediated Cyr61 induced breast cancer growth and invasion.
format Online
Article
Text
id pubmed-4111618
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41116182014-07-29 IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion Sarkissyan, Suren Sarkissyan, Marianna Wu, Yanyuan Cardenas, Jessica Koeffler, H. Phillip Vadgama, Jaydutt V. PLoS One Research Article BACKGROUND: Studies from our laboratory and others have shown that cysteine-rich 61 (Cyr61) may be involved in tumor proliferation and invasion. In earlier studies, we demonstrated increased insulin-like growth factor-I (IGF-1) is associated with breast tumor formation and poor clinical outcomes. In our current study we have investigated IGF-1 regulation of Cyr61 and whether targeting IGF-1 could inhibit Cyr61 induced tumor growth and proliferation. METHODS: Several ATCC derived normal and breast cancer cell lines were used in this study: MDA-MB231, BT474, MCF-7, and SKBR3. We also tested cells stably transfected in our laboratory with active Akt1 (pAkt; SKBR3/AA and MCF-7/AA) and dominant negative Akt1 (SKBR3/DN and MCF-7/DN). In addition, we used MCF-7 cells transfected with full length Cyr61 (CYA). Monolayer cultures treated with IGF-1 were analyzed for Cyr61 expression by RT-PCR and immunohistochemical staining. Migration assays and MTT based proliferation assays were used to determine invasive characteristics in response to IGF-1/Cyr61 activation. RESULTS: Cells with activated Akt have increased levels of Cyr61. Conversely, cells with inactive Akt have decreased levels of Cyr61. IGF-1 treatment increased Cyr61 expression significantly and cells with high level of Cyr61 demonstrate increased invasiveness and proliferation. Cyr61 overexpression and activation led to decrease in E-cadherin and decrease in FOXO1. Inhibition of the PI3K and MAPK pathways resulted in significant decrease in invasiveness and proliferation, most notably in the PI3K pathway inhibited cells. CONCLUSION: The findings of this study show that IGF-1 upregulates Cyr61 primarily through activation of the Akt-PI3K pathway. IGF-1 induced MAPK plays a partial role. Increase in Cyr61 leads to increase in breast cancer cell growth and invasion. Hence, targeting Cyr61 and associated pathways may offer an opportunity to inhibit IGF-1 mediated Cyr61 induced breast cancer growth and invasion. Public Library of Science 2014-07-25 /pmc/articles/PMC4111618/ /pubmed/25062088 http://dx.doi.org/10.1371/journal.pone.0103534 Text en © 2014 Sarkissyan et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Sarkissyan, Suren
Sarkissyan, Marianna
Wu, Yanyuan
Cardenas, Jessica
Koeffler, H. Phillip
Vadgama, Jaydutt V.
IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
title IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
title_full IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
title_fullStr IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
title_full_unstemmed IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
title_short IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
title_sort igf-1 regulates cyr61 induced breast cancer cell proliferation and invasion
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111618/
https://www.ncbi.nlm.nih.gov/pubmed/25062088
http://dx.doi.org/10.1371/journal.pone.0103534
work_keys_str_mv AT sarkissyansuren igf1regulatescyr61inducedbreastcancercellproliferationandinvasion
AT sarkissyanmarianna igf1regulatescyr61inducedbreastcancercellproliferationandinvasion
AT wuyanyuan igf1regulatescyr61inducedbreastcancercellproliferationandinvasion
AT cardenasjessica igf1regulatescyr61inducedbreastcancercellproliferationandinvasion
AT koefflerhphillip igf1regulatescyr61inducedbreastcancercellproliferationandinvasion
AT vadgamajayduttv igf1regulatescyr61inducedbreastcancercellproliferationandinvasion